Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravitreal triamcinolone versus laser therapy for diabetic macular edema
2004-005197-23Phase 3Active
- Sponsor
- University of Regensburg Eye Clinic
- Start
- May 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of triamcinolone in diabetic macular edema (DME) (2 arms), sponsored by University of Regensburg Eye Clinic. Primary endpoint: Change in visual acuity. Started May 2006; status: active.
02
Drugs
triamcinolone
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on 2004-005197-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-005197-23.